Poonawalla IB, Bowe AT, Tindal MC, Meah YA, Schwab P. A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists. Diabetes Res Clin Pract. 2021 May;175:108800. doi: 10.1016/j.diabres.2021.108800
Calderwood MS, Kawai AT, Jin R, Lee GM. Centers for medicare and medicaid services hospital-acquired conditions policy for central line-associated bloodstream infection (CLABSI) and cather-associated urinary tract infection (CAUTI) shows minimal impact on hospital reimbursement. Infect Control Hosp Epidemiol. 2018 Aug;39(8):897-901. doi: 10.1017/ice.2018.137
Hsu HE, Kawai AT, Wang R, Jentzsch MS, Rhee C, Horan K, Jin R, Goldmann D, Lee GM. The impact of the Medicaid healthcare-associated condition program on mediastinitis following coronary artery bypass graft. Infect Control Hosp Epidemiol. 2018 Jun;39(6):694-700. doi: 10.1017/ice.2018.69
Graz H, D'Souza VK, Alderson DEC, Graz M. Diabetes-related amputations create considerable public health burden in the UK. Diabetes Res Clin Pract. 2018 Jan;135:158-65. doi: 10.1016/j.diabres.2017.10.030
Climent M, Hidalgo N, Vidal O, Puig S, Iglesias M, Cuatrecasas M, Ramon JM, Garcia-Albeniz X, Grande L, Pera M. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2016 Jan;42(1):132-9. doi: 10.1016/j.ejso.2015.08.163
Calderwood MS, Vaz LE, Tse Kawai A, Jin R, Rett MD, Grant PS, Lee GM. Impact of hospital operating margin on central line-associated bloodstream infections following Medicare's hospital-acquired conditions payment policy. Infect Control Hosp Epidemiol. 2016 Jan;37(1):100-3. doi: 10.1017/ice.2015.250
Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Ball KE, Mines D, Wallace AE, Fraser VJ. Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol. 2015 Aug;36(8):907-14. doi: 10.1017/ice.2015.108
Kawai AT, Calderwood MS, Jin R, Soumerai SB, Vaz LE, Goldmann D, Lee GM. Impact of the Centers for Medicare and Medicaid Services hospital-acquired conditions policy on billing rates for 2 targeted healthcare-associated infections. Infect Control Hosp Epidemiol. 2015 Aug;36(8):871-7. doi: 10.1017/ice.2015.86
Vaz LE, Kleinman KP, Kawai AT, Jin R, Kassler WJ, Grant PS, Rett MD, Goldmann DA, Calderwood MS, Soumerai SB, Lee GM. Impact of Medicare's Hospital-Acquired Condition policy on infections in safety net and non-safety net hospitals. Infect Control Hosp Epidemiol. 2015 Jun;36(6):649-55. doi: 10.1017/ice.2015.38.
Olsen MA, Nickel KB, Wallace AE, Mines D, Fraser VJ, Warren DK. Stratification of surgical site infection by operative factors and comparison of infection rates after hernia repair. Infect Control Hosp Epidemiol. 2015 Mar;36(3):329-35. doi: 10.1017/ice.2014.44
Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S, Elliott J, Basarir H, REPOSE group. Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation. Diabetes Res Clin Pract. 2014 Dec;106(3):443-50. doi: 10.1016/j.diabres.2014.09.011
Warren DK, Nickel KB, Wallace AE, Mines D, Fraser VJ, Olsen MA. Can additional information be obtained from claims data to support surgical site infection diagnosis codes? Infect Control Hosp Epidemiol. 2014 Oct;35(S3):S124-32. doi: 10.1086/677830
Williams V, Rousculp MD, Price M, Coles T, Therrien MA, Griffin J, Hollis K, Toback S. Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation. J Sch Nurs. 2012 Aug 1;28(4):256-67.
Lee LJ, Fahrbach JL, Nelson LM, McLeod LD, Martin SA, Sun P, Weinstock RS. Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the DURABLE trial. Diabetes Res Clin Pract. 2010 Aug 1;89(2):157-66.
Hoerger TJ, Zhang P, Segel JE, Gregg EW, Venkat Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract. 2009 Dec 1;86(3):225-32.
Donatti C, Wild D, Horblyuk R, Beusterien KM, Anderson R, Arondekar B, DiBenedetti DB. Psychometric evaluation of the satisfaction with Oral Anti-Diabetic Agent Scale. Diabetes Res Clin Pract. 2008 Apr;80(1):108-13.